Must be due an update on the commissioning of the plant in India (3 days off 1 month since an update)
Panthera Expandable Graphite Joint Venture (“the JV”, India
• During the six month to 31 December 2023, significant progress was made in the effort to prepare for production at the Expandable Graphite JV site, which is scheduled to commence over the next month. A more advanced effluent treatment plant has been installed to achieve cost efficiency. As part of the full scale qualification process, a range of potential feed stock material has been sourced and tested at Metachem’s processing facility in Pune and the JV’s expandable graphite products were deemed suitable for a variety of potential uses.
• Just after the end of first half of the 2024 reporting period, Evion announced that commissioning activities have continued to an advanced level with substantial infrastructure completed to date.
• More recently, the JV directors met in Dubai with parties representing the buyers of the JV’s expandable graphite. These meetings focused on the establishment of fixed price terms for the first year of production at price levels that are within the JV’s budget guidelines, production planning to maximise revenue and marketing of the JV’s products in Australia and other parts of the world.
• Orders to acquire substantial volumes of grahite concentrate for the remainder of the calendar year 2024 will be concluded in the short term.
• Executives from Evion will be on site in March to review initial production and will provide regular updates to the market.
Please Tom can we have an update
- Forums
- ASX - By Stock
- EVION GROUP GENERAL DISCUSSION
Must be due an update on the commissioning of the plant in India...
- There are more pages in this discussion • 122 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EVG (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.341M |
Open | High | Low | Value | Volume |
2.7¢ | 2.7¢ | 2.7¢ | $2.364K | 87.54K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 350000 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 200000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 350000 | 0.026 |
4 | 232833 | 0.025 |
3 | 222410 | 0.024 |
3 | 312500 | 0.023 |
1 | 18000 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 200000 | 1 |
0.028 | 475941 | 1 |
0.029 | 26179 | 1 |
0.030 | 67825 | 3 |
0.031 | 209081 | 2 |
Last trade - 13.34pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
2.7¢ |
  |
Change
0.000 ( 3.85 %) |
|||
Open | High | Low | Volume | ||
2.7¢ | 2.7¢ | 2.7¢ | 24661 | ||
Last updated 13.34pm 06/05/2024 ? |
Featured News
EVG (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online